What does a 22% suppression of DHEA‑S (dehydroepiandrosterone sulfate) and complete suppression of 11‑deoxycortisol on a dexamethasone suppression test indicate about autonomous cortisol production and the need for further evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation of Dexamethasone Suppression Test Results

A 22% suppression of DHEA-S combined with complete suppression of 11-deoxycortisol following dexamethasone administration strongly suggests autonomous cortisol secretion (ACS) from an adrenal source, and you should proceed with additional confirmatory testing including late-night salivary cortisol and 24-hour urinary free cortisol measurements.

Understanding Your Test Results

DHEA-S Suppression Analysis

The 22% suppression of DHEA-S is inadequate and highly concerning for autonomous cortisol production. Here's why:

  • Normal physiology: In healthy individuals, dexamethasone suppresses ACTH secretion, which should subsequently suppress both cortisol AND DHEA-S production from the normal adrenal glands 1, 2
  • Your result: Only 22% suppression indicates the hypothalamic-pituitary-adrenal axis remains partially active despite dexamethasone, OR there is autonomous adrenal hormone production that is ACTH-independent
  • Low DHEA-S is a validated biomarker: Multiple studies demonstrate that suppressed DHEA-S levels (typically <60-75 µg/dL or DHEA-S ratio <1.7) have 75-80% sensitivity and 73-81% specificity for detecting ACS in patients with adrenal incidentalomas 3, 4
  • The paradox: While low absolute DHEA-S suggests ACS, your incomplete suppression after dexamethasone is the red flag here—it should suppress much more dramatically if your HPA axis were functioning normally

11-Deoxycortisol Complete Suppression

The complete suppression of 11-deoxycortisol is actually expected and appropriate with dexamethasone administration:

  • 11-deoxycortisol is an immediate precursor to cortisol in the steroidogenic pathway
  • When dexamethasone suppresses ACTH, 11-deoxycortisol should drop to undetectable levels in normal individuals 5, 6
  • This finding is consistent with but does not rule out ACS—it simply confirms that dexamethasone reached adequate blood levels and your normal adrenal tissue responded appropriately

What This Pattern Indicates

The combination suggests possible autonomous cortisol secretion because:

  1. Dissociation pattern: Your 11-deoxycortisol suppressed completely (indicating adequate dexamethasone levels and normal adrenal tissue response), but DHEA-S suppressed inadequately (suggesting either residual ACTH activity or autonomous production) 7, 6

  2. This is NOT a dexamethasone absorption issue: If you had malabsorbed dexamethasone, NEITHER steroid would suppress adequately. The selective pattern points to a pathologic process 2, 7

  3. Age considerations matter: DHEA-S naturally declines with age, so interpretation must use age- and sex-adjusted reference ranges. In elderly patients, even "low-normal" DHEA-S may be significant 8, 4

Required Next Steps

You need additional testing to confirm or exclude ACS 1, 2:

Mandatory Tests:

  • Late-night salivary cortisol (at least 2-3 collections): Assesses loss of normal circadian rhythm, which occurs in ACS. Collect at your usual bedtime, not necessarily midnight 1

    • Caveat: Avoid smoking on collection day, don't use steroid-containing lotions, and collect on quiet evenings at home to avoid false positives 2
  • 24-hour urinary free cortisol (at least 2-3 collections): Measures total cortisol production independent of binding proteins 1

    • Caveat: High variability (up to 50%), so multiple collections are essential 1
  • Morning plasma ACTH: Should be suppressed (<10 pg/mL or <2.2 pmol/L) in true ACS 9, 4

  • Measure dexamethasone level: If not already done, simultaneous measurement of dexamethasone with cortisol confirms adequate drug absorption and reduces false-positive results 1, 6

    • The cutoff for adequate dexamethasone is ≥3.48 nmol/L 6

Additional Considerations:

  • What was your post-dexamethasone cortisol level? This is the most critical piece of information:

    • <1.8 µg/dL (50 nmol/L): Excludes ACS 1, 2
    • 1.8-5.0 µg/dL: Possible ACS, requires additional criteria 9
    • 5.0 µg/dL: Highly suggestive of ACS 1

  • Absolute DHEA-S value matters: If your absolute DHEA-S is <60-75 µg/dL (age-adjusted), this increases suspicion for ACS regardless of percent suppression 3, 4

Common Pitfalls to Avoid

  1. Don't rely on a single test: The diagnosis of ACS requires multiple concordant abnormalities, not just one abnormal result 1, 9

  2. Check for interfering medications: CYP3A4 inducers (phenobarbital, carbamazepine, St. John's wort) can cause false-positive DST results by increasing dexamethasone metabolism 1, 2, 7

  3. Consider medication interactions: Fluoxetine, cimetidine, and diltiazem inhibit dexamethasone metabolism and can cause false-negative results 2, 7

  4. Estrogen effects: Oral estrogens increase cortisol-binding globulin and can falsely elevate total cortisol measurements 1, 2

  5. Don't ignore clinical context: Even with biochemical abnormalities, assess for hypertension, diabetes, dyslipidemia, and osteoporosis—these comorbidities support the diagnosis of clinically significant ACS 10

Diagnostic Algorithm for Your Situation

If post-DST cortisol was ≥1.8 µg/dL AND DHEA-S <60-75 µg/dL (age-adjusted):

  • Proceed with late-night salivary cortisol (2-3 collections) AND 24-hour UFC (2-3 collections)
  • Measure morning ACTH
  • If ≥2 of these are abnormal → Diagnosis of ACS is confirmed 9

If post-DST cortisol was <1.8 µg/dL:

  • ACS is excluded regardless of DHEA-S results 1, 2
  • The DHEA-S finding may reflect normal age-related decline or other factors

If only one additional test is abnormal:

  • Consider adrenal imaging characteristics (size, density, washout)
  • Assess for clinical features of cortisol excess
  • Consider repeat testing in 6-12 months 9

The key is that your pattern is suspicious but not diagnostic—you need the complete biochemical picture before making treatment decisions 1, 3, 9.

References

Guideline

the diagnosis of cushing's syndrome: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2008

Related Questions

Which laboratory tests should be ordered after a suppressed cortisol level is identified?
How should elevated dehydroepiandrosterone (DHEA) be evaluated and managed in an adult?
Does a low dehydroepiandrosterone sulfate (DHEA‑S) level make pituitary adrenocorticotropic hormone (ACTH)‑dependent Cushing disease less likely?
In a 47‑year‑old woman with a DHEA‑sulfate level of 199 ng/dL and a morning cortisol level of 7.6 µg/dL, what is the clinical significance and what evaluation and management steps are recommended?
What is the appropriate dosing regimen of dehydroepiandrosterone (DHEA) for healthy adults, older adults, and patients with adrenal insufficiency?
What alternative intravenous dextrose regimen can be used for an adult patient who is unable to take oral glucose or is unconscious?
In an unresponsive patient, how do I distinguish coma from catatonia and what initial workup and treatment should be undertaken?
What is the recommended management for acute bleeding due to vitamin K deficiency, including IV (intravenous) phytonadione dosing, reversal of warfarin anticoagulation with FFP (fresh‑frozen plasma) or PCC (prothrombin complex concentrate), monitoring of INR (International Normalized Ratio), and supportive care?
What is the recommended treatment for extraskeletal (soft‑tissue) osteosarcoma?
How can markedly elevated vitamin B6 (pyridoxine) and vitamin B12 (cobalamin) levels be reduced in a patient with both MTHFR gene variants?
What is the recommended volume of packed red blood cells (PRBCs) or whole blood to transfuse to a neonate per kilogram of body weight?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.